Nucleic Acids & Peptides Summit
推动中国下一代RNA与多肽疗法发展
探索、连接并合作,涵盖RNA疗法、寡核苷酸和多肽类药物
推动中国下一波治疗创新浪潮
加入Nucleic Acids & Peptides Summit，与全球创新者、合作伙伴和监管专家建立联系，共同推进mRNA、siRNA、ASO、RNA编辑、多肽、多肽药物偶联物以及下一代口服多肽在中国快速发展的生物制药领域中的应用。
久经验证的卓越品质
基于RNA Leaders和TIDES的成功经验, Nucleic Acids & Peptides Summit将世界级的内容和国际化的交流机会带到中国。
融入全球创新生态系统
与全球领先的生物技术公司、顶尖研究机构、专业CDMO和活跃投资者直接对话，携手推动mRNA、siRNA、多肽偶联物和新兴RNA技术的突破性进展。
加速市场准入与拓展
汇聚监管权威专家和成功案例分享者的实战经验，全面掌握核酸和多肽治疗药物的监管审批路径、生产合规要求和商业化落地策略。
架起创新与全球机遇的桥梁
促进创新企业与国际制药巨头、技术供应商和投资机构之间的战略合作，，建立深度联系,将交流转化为切实的合作项目、战略伙伴关系和商业机遇。
探索RNA治疗创新，全面掌握多肽治疗从发现到上市的完整生态系统
Nucleic acid therapeutics track
- Discover how companies and research institutions are leveraging nucleic acid platforms to address rare diseases prevalent in Asian populations, with focus on regulatory pathways and patient access strategies.
- Examine growing capabilities in mRNA vaccine development for oncology, featuring case studies from biotech leaders and strategies for clinical translation within evolving regulatory frameworks.
- Master nucleic acid therapeutic design principles with emphasis on delivery technologies, including lipid nanoparticles and novel formulation approaches.
- Learn from experts on streamlining siRNA and ASO development, addressing manufacturing capabilities, supply chain considerations, and clinical development strategies.
- Explore expanding mRNA manufacturing infrastructure, quality control standards, and strategies for scaling production to meet demand and export opportunities.
- Discover emerging RNA editing technologies and epigenetic approaches being pioneered by research institutions and biotech companies.
Peptide therapeutics track
- Explore innovative peptide-based cancer therapies targeting high-prevalence cancers, with insights on combination strategies and regulatory approval pathways.
- Examine breakthrough peptide therapies addressing diabetes and obesity, with focus on market access and reimbursement strategies.
- Master advanced peptide design approaches with perspectives from leading research institutions and biotech companies, including AI-driven discovery platforms.
- Navigate NMPA requirements, clinical trial design considerations, and biomarker strategies specific to peptide therapeutic development, with case studies from successful programs.
- Discover innovative oral peptide delivery technologies addressing formulation challenges and manufacturing scalability.
Address CMC requirements, analytical method development, and process optimization leveraging expanding peptide CDMO capabilities. - Explore advances in peptide-drug conjugate platforms, combining strengths in peptide chemistry with targeted payload delivery for precision oncology.
获取最新活动更新
注册以获取最新的活动更新和信息。
我们不会在未经同意的情况下分享任何数据
任何联系您售卖参会者名单的外部供应商都未经大会主办方批准，与大会主办方无关。
